The results showed that the high expression of lncRNAs (CRNDE, TUG1) reduces the overall survival rate of AML patients, and the high expression of lncRNA ZEB2-AS1 reduces the disease-free survival rate of AML patients. This evidence concerns the gene ZEB2 and acute myeloid leukemia.